Roberto Tavolari Jortieke C, Joaquim A, Fumagalli F
RSC Med Chem. 2024; .
PMID: 39493226
PMC: 11528911.
DOI: 10.1039/d4md00508b.
Zhang Y, Wang S, Chen X, Cui P, Chen J, Zhang W
mBio. 2024; 15(2):e0207323.
PMID: 38179948
PMC: 10865796.
DOI: 10.1128/mbio.02073-23.
Suman S, Chandrasekaran N, George Priya Doss C
Clin Microbiol Rev. 2023; 36(4):e0008823.
PMID: 38032192
PMC: 10732062.
DOI: 10.1128/cmr.00088-23.
Xia X
Antibiotics (Basel). 2023; 12(9).
PMID: 37760664
PMC: 10526031.
DOI: 10.3390/antibiotics12091367.
Dokrungkoon T, Tulyaprawat O, Suwannakarn K, Ngamskulrungroj P
Front Microbiol. 2023; 14:1171861.
PMID: 37492259
PMC: 10364472.
DOI: 10.3389/fmicb.2023.1171861.
The past, present and future of tuberculosis treatment.
Bi K, Cao D, Ding C, Lu S, Lu H, Zhang G
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 51(6):657-668.
PMID: 36915970
PMC: 10262004.
DOI: 10.3724/zdxbyxb-2022-0454.
Bacterial Enoyl-Reductases: The Ever-Growing List of Fabs, Their Mechanisms and Inhibition.
Hopf F, Roth C, de Souza E, Galina L, Czeczot A, Machado P
Front Microbiol. 2022; 13:891610.
PMID: 35814645
PMC: 9260719.
DOI: 10.3389/fmicb.2022.891610.
Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.
Reingewertz T, Meyer T, McIntosh F, Sullivan J, Meir M, Chang Y
Antimicrob Agents Chemother. 2019; 64(2).
PMID: 31767723
PMC: 6985715.
DOI: 10.1128/AAC.01899-19.
Pyrazinoic Acid Inhibits the Bifunctional Enzyme (Rv2783) in by Competing with tmRNA.
He L, Cui P, Shi W, Li Q, Zhang W, Li M
Pathogens. 2019; 8(4).
PMID: 31718097
PMC: 6963974.
DOI: 10.3390/pathogens8040230.
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis.
Vilcheze C, Jacobs Jr W
J Mol Biol. 2019; 431(18):3450-3461.
PMID: 30797860
PMC: 6703971.
DOI: 10.1016/j.jmb.2019.02.016.
Molecular Analysis of Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis.
Purkan P, Ihsanawati I, Natalia D, Syah Y, Retnoningrum D, Siswanto I
J Med Life. 2018; 11(2):160-167.
PMID: 30140323
PMC: 6101688.
Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis.
Zhang Y, Zhang J, Cui P, Zhang Y, Zhang W
Antimicrob Agents Chemother. 2017; 61(8).
PMID: 28584158
PMC: 5527661.
DOI: 10.1128/AAC.00940-17.
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.
Vilcheze C, Jacobs Jr W
Microbiol Spectr. 2015; 2(4):MGM2-0014-2013.
PMID: 26104204
PMC: 6636829.
DOI: 10.1128/microbiolspec.MGM2-0014-2013.
Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis.
Shi W, Chen J, Feng J, Cui P, Zhang S, Weng X
Emerg Microbes Infect. 2015; 3(8):e58.
PMID: 26038753
PMC: 4150287.
DOI: 10.1038/emi.2014.61.
Sarcoidosis--scientific progress and clinical challenges.
Chen E, Moller D
Nat Rev Rheumatol. 2011; 7(8):457-67.
PMID: 21750528
DOI: 10.1038/nrrheum.2011.93.
Precise null deletion mutations of the mycothiol synthesis genes reveal their role in isoniazid and ethionamide resistance in Mycobacterium smegmatis.
Xu X, Vilcheze C, Av-Gay Y, Gomez-Velasco A, Jacobs Jr W
Antimicrob Agents Chemother. 2011; 55(7):3133-9.
PMID: 21502624
PMC: 3122461.
DOI: 10.1128/AAC.00020-11.
Relationship between mutation of serine residue at 315th position in M. tuberculosis catalase-peroxidase enzyme and Isoniazid susceptibility: an in silico analysis.
Purohit R, Rajendran V, Sethumadhavan R
J Mol Model. 2010; 17(4):869-77.
PMID: 20593210
DOI: 10.1007/s00894-010-0785-6.
Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.
Wang F, Jain P, Gulten G, Liu Z, Feng Y, Ganesula K
Antimicrob Agents Chemother. 2010; 54(9):3776-82.
PMID: 20566771
PMC: 2935018.
DOI: 10.1128/AAC.00453-10.
PhoY2 but not PhoY1 is the PhoU homologue involved in persisters in Mycobacterium tuberculosis.
Shi W, Zhang Y
J Antimicrob Chemother. 2010; 65(6):1237-42.
PMID: 20360062
PMC: 2868530.
DOI: 10.1093/jac/dkq103.
Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance.
Iwamoto T, Yoshida S, Suzuki K, Wada T
Antimicrob Agents Chemother. 2008; 52(10):3805-9.
PMID: 18694954
PMC: 2565899.
DOI: 10.1128/AAC.00579-08.